NEC OncoImmunity AS
Brandon Malone is an experienced bioinformatics professional currently serving as the Infectious Disease Bioinformatics Manager and Principal Data Scientist at NEC OncoImmunity AS since February 2022. Previously, Malone held the position of Bioinformatics Team Leader at CeCaVa GmbH & CO. KG for six months in 2021 and served as a Senior Researcher at NEC Laboratories Europe from May 2017 to June 2021. Earlier roles include Postdoctoral Researcher positions at Universität Heidelberg and the Max Planck Institute for the Biology of Ageing, as well as at the Helsinki Institute for Information Technology. Brandon Malone earned a Ph.D. in Machine Learning from Mississippi State University in 2012.
This person is not in any offices
NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.